You are viewing the site in preview mode
Skip to main content
| |
Total N = 1422
|
ECD n = 325
|
Non-ECD n = 1097
|
p value
|
|---|
|
Donor characteristics
| | | | |
|
Age at time of death, years
| | | | |
|
Mean (SD)
|
47 (14)
|
63 (6)
|
42 (12)
|
<0.001
|
|
<50 years
|
729 (51 %)
|
0
|
729 (66 %)
|
<0.001
|
|
50 to 59 years
|
433 (30 %)
|
65 (20 %)
|
368 (34 %)
|
|
≥60 years
|
260 (18 %)
|
260 (80 %)
|
0
|
|
Women
|
616 (43 %)
|
152 (47 %)
|
464 (42 %)
|
0.153
|
|
Body mass index (kg/m2)
| | | | |
|
Mean (SD)
|
27.2 (5.7)
|
28.5 (4.9)
|
26.8 (5.9)
|
<0.001
|
|
Pre-terminal serum creatinine, μmol/L
| | | | |
|
Median (Q1–Q3)
|
66 (53-83)
|
68 (54-87)
|
66 (53-82)
|
<0.001
|
|
Pre-terminal eGFR, mL/min
| | | | |
|
Median (Q1–Q3)
|
99 (77–127)
|
84 (68–110)
|
102 (81–130)
|
<0.001
|
|
Cause of death
| | | | |
|
Cerebrovascular accident
|
172 (12 %)
|
71 (22 %)
|
101 (9 %)
|
<0.001
|
|
Trauma
|
119 (8 %)
|
23 (7 %)
|
96 (9 %)
|
|
Other
|
1131 (80 %)
|
231 (71 %)
|
900 (82 %)
|
|
Past medical history
| | | | |
|
Diabetes mellitus
|
147 (10 %)
|
68 (21 %)
|
87 (8 %)
|
<0.001
|
|
Hyperlipidemia
|
33 (2 %)
|
11 (3 %)
|
26 (2 %)
|
0.147
|
|
Hypertension
|
518 (36 %)
|
223 (69 %)
|
295 (27 %)
|
<0.001
|
|
Donation after circulatory death
|
205 (14)
|
22 (7 %)
|
183 (17 %)
|
<0.001
|
|
Transplant Characteristics
| | | | |
|
Year of transplant
| | | | |
|
2005
|
150 (11 %)
|
33 (10 %)
|
117 (11 %)
|
0.414
|
|
2006
|
208 (15 %)
|
44 (14 %)
|
164 (15 %)
|
|
2007
|
241 (17 %)
|
54 (17 %)
|
187 (17 %)
|
|
2008
|
213 (15 %)
|
52 (16 %)
|
161 (15 %)
|
|
2009
|
278 (20 %)
|
64 (20 %)
|
214 (20 %)
|
|
2010
|
266 (19 %)
|
57 (18 %)
|
209 (19 %)
|
|
2011 (until March 31)
|
66 (5 %)
|
21 (6 %)
|
45 (4 %)
|
|
HLA mismatch (max 6)
| | | | |
|
0
|
16 (1 %)
|
≤5
|
16 (1 %)
|
0.269
|
|
1
|
32 (2 %)
|
9 (3 %)
|
23 (2 %)
|
|
2
|
62 (4 %)
|
17 (5 %)
|
45 (4 %)
|
|
3
|
127 (9 %)
|
28 (9 %)
|
99 (9 %)
|
|
4
|
300 (21 %)
|
61 (19 %)
|
239 (22 %)
|
|
5
|
598 (42 %)
|
135 (42 %)
|
463 (42 %)
|
|
6
|
287 (20 %)
|
75 (23 %)
|
212 (19 %)
|
|
Pulsatile perfusion pump use
|
275 (19 %)
|
111 (34 %)
|
164 (15 %)
|
<0.001
|
|
Cold ischemia time, minutes
| | | | |
|
Median (Q1–Q3)
|
691 (579–813)
|
691 (574–772)
|
691 (580–829)
|
0.098
|
- Cells with ≤5 observations were suppressed to prevent indirect identification of individuals
-
HLA human leukocyte antigen
